{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:43:20Z","timestamp":1775871800110,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cjcopen.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cjco.2025.11.017","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T07:50:55Z","timestamp":1763797855000},"page":"448-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mortality Benefit of Microaxial Flow Pump Use in Infarct-Related Cardiogenic Shock: a Bayesian Reanalysis of the DanGer Shock Trial"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1989-4342","authenticated-orcid":false,"given":"Marco","family":"Tomasino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garazi","family":"Urio-Garmendia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"R\u00f3denas-Alesina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aitor","family":"Uribarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Ferreira-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2025.11.017_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA Statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat"},{"issue":"Suppl 1","key":"10.1016\/j.cjco.2025.11.017_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00031305.2019.1583913","article-title":"Moving to a world beyond \u201c p < 0.05.\u201d","volume":"73","author":"Wasserstein","year":"2019","journal-title":"Am Stat"},{"key":"10.1016\/j.cjco.2025.11.017_bib3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(24)01295-9","article-title":"Bayesian statistics for clinical research","volume":"404","author":"Goligher","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2025.11.017_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezaf139","article-title":"Statistical primer: an introduction into the principles of Bayesian statistical analyses in clinical trials","volume":"67","author":"Heuts","year":"2025","journal-title":"Eur J Cardio-Thorac Surg"},{"key":"10.1016\/j.cjco.2025.11.017_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jclinepi.2008.07.006","article-title":"Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials","volume":"62","author":"Wijeysundera","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cjco.2025.11.017_bib6","series-title":"Bayesian analysis: a practical approach to interpret clinical trials and create clinical practice guidelines","volume":"10","author":"Bittl","year":"2017"},{"key":"10.1016\/j.cjco.2025.11.017_bib7","first-page":"1415","article-title":"Bayesian analyses of cardiovascular trials\u2014bringing added value to the table","volume":"37","author":"Brophy","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2025.11.017_bib8","first-page":"191","article-title":"Extracorporeal life support in cardiac arrest: a post hoc Bayesian re-analysis of the INCEPTION trial","volume":"13","author":"Heuts","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cjco.2025.11.017_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/jce.16552","article-title":"A Bayesian interpretation of CABANA and other randomized controlled trials for catheter ablation in patients with atrial fibrillation","volume":"36","author":"Nogueira","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjco.2025.11.017_bib10","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.jcin.2024.09.071","article-title":"Bayesian reanalyses of the trials TOMAHAWK and COACT","volume":"17","author":"Thevathasan","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjco.2025.11.017_bib11","first-page":"30","article-title":"Bayesian analytical methods in cardiovascular clinical trials: why, when, and how","volume":"41","author":"Heuts","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2025.11.017_bib12","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2018.14276","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial","volume":"320","author":"Goligher","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2025.11.017_bib13","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"M\u00f8ller","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2025.11.017_bib14","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/CCM.0000000000001670","article-title":"The fragility index in multicenter randomized controlled critical care trials","volume":"44","author":"Ridgeon","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cjco.2025.11.017_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jcrc.2019.08.020","article-title":"P-values and significance: The null hypothesis that they are not related is correct","volume":"54","author":"Einav","year":"2019","journal-title":"J Crit Care"},{"key":"10.1016\/j.cjco.2025.11.017_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13054-025-05307-9","article-title":"Death by p-value: the overreliance on p-values in critical care research","volume":"29","author":"Patel","year":"2025","journal-title":"Crit Care"},{"key":"10.1016\/j.cjco.2025.11.017_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ahj.2019.04.019","article-title":"Rationale and design of DanGer shock: Danish-German cardiogenic shock trial","volume":"214","author":"Udesen","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2025.11.017_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ahj.2022.10.078","article-title":"Danish-German cardiogenic shock trial\u2014DanGer shock: trial design update","volume":"255","author":"M\u00f8ller","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2025.11.017_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.resuscitation.2020.07.022","article-title":"Cardiogenic shock and cardiac arrest complicating ST-segment elevation myocardial infarction in the United States, 2000\u20132017","volume":"155","author":"Vallabhajosyula","year":"2020","journal-title":"Resuscitation"},{"key":"10.1016\/j.cjco.2025.11.017_bib20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/SHK.0000000000001895","article-title":"Cardiogenic shock complicating ST-segment elevation myocardial infarction: an 18-year analysis of temporal trends, epidemiology, management, and outcomes","volume":"57","author":"Vallabhajosyula","year":"2022","journal-title":"Shock"},{"key":"10.1016\/j.cjco.2025.11.017_bib21","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2023.06.026","article-title":"Long-term outcomes of cardiogenic shock complicating myocardial infarction","volume":"82","author":"Sterling","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2025.11.017_bib22","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2025.11.017_bib23","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jacc.2024.11.009","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes","volume":"85","author":"Rao","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2025.11.017_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12992-018-0348-7","article-title":"Population aging and migration\u2014history and UN forecasts in the EU-28 and its east and south near neighborhood\u2014one century perspective 1950\u20132050","volume":"14","author":"Jakovljevic","year":"2018","journal-title":"Global Health"},{"key":"10.1016\/j.cjco.2025.11.017_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41597-025-04380-7","article-title":"A national synthetic populations dataset for the United States","volume":"12","author":"Rineer","year":"2025","journal-title":"Sci Data"},{"key":"10.1016\/j.cjco.2025.11.017_bib26","series-title":"R2jags: using R to run \u201cJAGS.\u201d","author":"Su","year":"2008"},{"key":"10.1016\/j.cjco.2025.11.017_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/aas.13725","article-title":"Interpreting the results of clinical trials, embracing uncertainty: a Bayesian approach","volume":"65","author":"Frost","year":"2021","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.cjco.2025.11.017_bib28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/sim.10000","article-title":"Confidence distributions for treatment effects in clinical trials: posteriors without priors","volume":"43","author":"Marschner","year":"2024","journal-title":"Stat Med"},{"key":"10.1016\/j.cjco.2025.11.017_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.202006-2381CP","article-title":"Using Bayesian methods to augment the interpretation of critical care trials. An overview of theory and example reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial","volume":"203","author":"Zampieri","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjco.2025.11.017_bib30","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1007\/s12630-023-02557-5","article-title":"Interpreting frequentist hypothesis tests: insights from Bayesian inference","volume":"70","author":"Sidebotham","year":"2023","journal-title":"Can J Anesthes"},{"key":"10.1016\/j.cjco.2025.11.017_bib31","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMe2402310","article-title":"Mechanical circulatory support in cardiogenic shock \u2014 persistence and progress","volume":"390","author":"Rao","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2025.11.017_bib32","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.cjco.2025.11.017_bib33","doi-asserted-by":"crossref","DOI":"10.1007\/s12265-025-10703-1","article-title":"Bayesian reanalysis of mortality outcomes in cardiovascular trials: addressing limitations of traditional significance testing [e-pub ahead of print]","author":"Nakhl\u00e9","year":"2025","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.cjco.2025.11.017_bib34","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2025.11.017_bib35","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2025.11.017_bib36","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2025.11.017_bib37","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.2020.0254","article-title":"Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock","volume":"323","author":"Dhruva","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2025.11.017_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.119.044007","article-title":"The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support","volume":"141","author":"Amin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2025.11.017_bib39","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCULATIONAHA.121.058229","article-title":"Percutaneous transvalvular microaxial flow pump support in cardiology","volume":"145","author":"L\u00fcsebrink","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2025.11.017_bib40","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1161\/CIR.0000000000000959","article-title":"Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the American Heart Association","volume":"143","author":"Henry","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2025.11.017_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jclinepi.2016.11.016","article-title":"The minimal clinically important difference raised the significance of outcome effects above the statistical level, with methodological implications for future studies","volume":"82","author":"Angst","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cjco.2025.11.017_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamacardio.2024.4197","article-title":"Microaxial flow pump hemodynamic and metabolic effects in infarct-related cardiogenic shock","volume":"10","author":"Udesen","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjco.2025.11.017_bib43","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.jacc.2024.08.056","article-title":"Using selection criteria from the DanGer shock trial in a contemporary cohort with cardiogenic shock","volume":"84","author":"O\u2019Brien","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2025.11.017_bib44","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.31123","article-title":"Post hoc bias in treatment decisions","volume":"7","author":"Redelmeier","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjco.2025.11.017_bib45","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/biom.13197","article-title":"Optimal approximate conversions of odds ratios and hazard ratios to risk ratios","volume":"76","author":"VanderWeele","year":"2020","journal-title":"Biometrics"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X25006997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X25006997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:43:40Z","timestamp":1775868220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X25006997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2589790X25006997"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2025.11.017","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality Benefit of Microaxial Flow Pump Use in Infarct-Related Cardiogenic Shock: a Bayesian Reanalysis of the DanGer Shock Trial","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2025.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}